We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

48 hedge funds and large institutions have $26.7M invested in Bio-Path Holdings Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

12% more funds holding

Funds holding: 4348 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less capital invested

Capital invested by funds: $28.1M → $26.7M (-$1.36M)

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
16
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$115K
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$105K -$9.69K -2 -10%
Creative Planning
28
Creative Planning
Kansas
$95K
NFA
29
Nationwide Fund Advisors
Ohio
$71K
Deutsche Bank
30
Deutsche Bank
Germany
$68K +$48.4K +10 +333%
BA
31
BlackRock Advisors
Delaware
$67K
AIG
32
American International Group
New York
$64K
IIC
33
Ironwood Investment Counsel
Arizona
$60K
VOYA Investment Management
34
VOYA Investment Management
Georgia
$60K
Wells Fargo
35
Wells Fargo
California
$56K +$9.69K +2 +25%
CS
36
Credit Suisse
Switzerland
$46K
Legal & General Group
37
Legal & General Group
United Kingdom
$43K +$19.4K +4 +100%
UBS Group
38
UBS Group
Switzerland
$23K +$19.4K +4 New
HSBC Holdings
39
HSBC Holdings
United Kingdom
$21K +$19.4K +4 New
VKH
40
Virtu KCG Holdings
New York
$20K -$4.84K -1 -20%
Goldman Sachs
41
Goldman Sachs
New York
$19K -$14.5K -3 -43%
Bank of America
42
Bank of America
North Carolina
$19K +$14.5K +3 +300%
ProShare Advisors
43
ProShare Advisors
Maryland
$19K +$19.4K +4 New
GRP
44
Global Retirement Partners
California
$18K +$14.5K +3 New
AB
45
Amalgamated Bank
New York
$15K +$14.5K +3 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$8K +$4.84K +1 New
MAM
47
Meeder Asset Management
Ohio
$5K +$4.84K +1 New
BlackRock
48
BlackRock
New York
$4K
Barclays
49
Barclays
United Kingdom
$2K
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$1.07K -$9.69K -2 Closed

BPTH Hedge Fund Activity: Q4 2016 in Review

48 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2016, worth a combined $26.7M — down 4.8% from $28.1M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BPTH positions and 5 closed out — a net gain of 5 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $615K. The largest seller was Raymond James Financial Services Advisors, cutting an estimated $1.45M.

  • 48 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2016, up from 43 in Q3 2016.
  • Funds reported $26.7M of Bio-Path Holdings Inc stock for Q4 2016, down 4.8% quarter-over-quarter.
  • 10 funds opened new Bio-Path Holdings Inc positions in Q4 2016 and 5 closed out, a net change of +5 holders.
  • The largest Bio-Path Holdings Inc buyer in Q4 2016 was Millennium Management, an estimated $615K added.
  • The largest Bio-Path Holdings Inc seller in Q4 2016 was Raymond James Financial Services Advisors, an estimated $1.45M sold.

Based on aggregated 13F filings for Q4 2016.